Literature DB >> 15911097

Human tissue kallikrein gene family: applications in cancer.

Christina V Obiezu1, Eleftherios P Diamandis.   

Abstract

Human tissue kallikrein genes, located on the long arm of chromosome 19, are a subgroup of the serine protease family of proteolytic enzymes. Initially thought to consist of three members, the human kallikrein locus has now been extended and includes 15 tandemly located genes. These genes, and their protein products, share a high degree of homology and are expressed in a wide array of tissues, mainly those that are under steroid hormone control. PSA (hK3) is one of the human kallikreins, and is the most useful tumor marker for prostate cancer screening, diagnosis, prognosis and monitoring. hK2, another prostate-specific kallikrein, has also been proposed as a complementary prostate cancer biomarker. In the past 5 years, the newly discovered kallikreins (KLK4-KLK15) have been associated with several types of cancer. For example, hK4, hK5, hK6, hK7, hK8, hK10, hK11, hK13 and hK14 are emerging biomarkers for ovarian, breast, prostate and testicular cancer. New evidence raises the possibility that some kallikreins are directly involved with cancer progression. We here review the evidence linking kallikreins and cancer and their applicability as novel biomarkers for cancer diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15911097     DOI: 10.1016/j.canlet.2004.09.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  35 in total

1.  Human Tissue Kallikreins in Polymorphous Adenocarcinoma: A Polymerase Chain Reaction and Immunohistochemical Study.

Authors:  Jacqueline Cox; Zia Khan; Linda Jackson-Boeters; Jerrold Armstrong; Mark Darling
Journal:  Head Neck Pathol       Date:  2020-06-26

Review 2.  New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family.

Authors:  Nashmil Emami; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

3.  The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.

Authors:  Hongyan Yuan; Geeta Upadhyay; Jin Lu; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2012-03-16

Review 4.  Kallistatin suppresses cancer development by multi-factorial actions.

Authors:  Julie Chao; Pengfei Li; Lee Chao
Journal:  Crit Rev Oncol Hematol       Date:  2017-03-14       Impact factor: 6.312

5.  Development of a survival prediction model for gastric cancer using serine proteases and their inhibitors.

Authors:  Ke-Feng Lei; Bing-Ya Liu; Xiao-Qing Zhang; Xiao-Long Jin; Yan Guo; Min Ye; Zheng-Gang Zhu
Journal:  Exp Ther Med       Date:  2011-09-21       Impact factor: 2.447

6.  Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors.

Authors:  Maroulio Talieri; Marita Zoma; Marina Devetzi; Andreas Scorilas; Alexandros Ardavanis
Journal:  Tumour Biol       Date:  2012-04-03

7.  Polymorphisms in innate immunity genes and lung cancer risk in Xuanwei, China.

Authors:  Min Shen; Roel Vermeulen; Preetha Rajaraman; Idan Menashe; Xingzhou He; Robert S Chapman; Meredith Yeager; Gilles Thomas; Laurie Burdett; Amy Hutchinson; Jeff Yuenger; Stephen Chanock; Qing Lan
Journal:  Environ Mol Mutagen       Date:  2009-05       Impact factor: 3.216

8.  Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.

Authors:  Jeremy G Stone; Raj K Rolston; Masumi Ueda; Hyoung-Gon Lee; Sandy L Richardson; Rudy J Castellani; George Perry; Mark A Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-10-20

Review 9.  Pathogenesis of ovarian cancer: clues from selected overexpressed genes.

Authors:  Ie-Ming Shih; Ben Davidson
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

10.  A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus.

Authors:  Carolyn A Goard; Irvin L Bromberg; Marc B Elliott; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2007-09-15       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.